Biogen Is Dropping Controversial Alzheimer's Drug Aduhelm
WEDNESDAY, Jan. 31, 2024 -- Biogen, maker of the Alzheimer's medicine Aduhelm, announced Wednesday that it would "discontinue the development and commercialization" of the controversial drug. Biogen will return the rights to Aduhelm to Neurimmune,...